Warning Letter — vape4sale.com
The FDA issued a Warning Letter to vape4sale.com on May 15, 2026, regarding non-compliance identified by the Center for Tobacco Products. The notice was published on May 19, 2026, as part of the agency's enforcement and inspection activities.
This action primarily affects the operator of vape4sale.com and serves as a notification for online retailers and distributors of electronic nicotine delivery systems (ENDS) and tobacco products.
The issuance of this letter suggests ongoing FDA scrutiny of online retailers within the tobacco and nicotine space. This enforcement demonstrates that the Center for Tobacco Products is actively monitoring digital sales channels for compliance with regulatory requirements, which likely include marketing authorization status and labeling standards. Regulatory teams at similar firms should consider this a signal that e-commerce platforms are high-priority targets for CTP compliance monitoring.
Retailers of tobacco and nicotine products should conduct audits of online storefronts to ensure all products have valid marketing authorizations. Compliance teams must verify that marketing claims do not exceed the scope of authorized product descriptors.
FDA Warning Letter issued to: vape4sale.com. 05/15/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vape4salecom-729728-05152026
Open in openFDA / FDA.gov